Intensity Therapeutics, Inc.
INTS
$4.04
$0.020.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.16M | -10.69M | -11.61M | -11.74M | -12.58M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.72M | 1.98M | 2.03M | 2.45M | 2.48M |
| Change in Net Operating Assets | 487.00K | -356.00K | 347.00K | -209.00K | -990.00K |
| Cash from Operations | -8.95M | -9.07M | -9.23M | -9.50M | -11.09M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 3.10M |
| Cash from Investing | -- | -- | -- | 0.00 | 3.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.20M | 20.19M | 20.38M | 15.61M | 8.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -933.00K | -1.81M | -1.82M | -1.82M | -1.60M |
| Cash from Financing | 16.27M | 18.39M | 18.56M | 13.79M | 6.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.31M | 9.32M | 9.33M | 4.29M | -1.03M |